DOI:
10.1055/s-00000068
Seminars in Interventional Radiology
LinksClose Window
References
Riss D, Burian M, Wolf A, Kranebitter V, Kaider A, Arnoldner C.
Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: a double-blind, randomized, placebo-controlled trial.
Head Neck 2015;
37 (06) 783-787
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.